05/20/2025
4:34 PM | Aura Biosciences (Issuer)
Gibney Anthony S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:43 PM | Aura Biosciences (Issuer)
Johnson David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
6:13 AM | Aura Biosciences (Filer)
| Form 424B5 | |
05/15/2025
5:38 AM | Aura Biosciences (Filer)
| Form 424B5 | |
05/15/2025
5:02 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
5:05 AM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
2:28 PM | Aura Biosciences (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/13/2025
4:28 PM | Aura Biosciences (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
04/24/2025
3:15 PM | Aura Biosciences (Filer)
| Form DEF 14A | |
04/24/2025
3:17 PM | Aura Biosciences (Filer)
| Form DEFA14A | |
04/24/2025
3:18 PM | Aura Biosciences (Filer)
| Form ARS | |
Get the Latest News and Ratings for AURA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aura Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
04/16/2025
7:36 PM | Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
7:36 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
7:37 PM | Aura Biosciences (Subject)
Kilroy Conor (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2025
7:37 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2025
4:57 PM | Aura Biosciences (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
04/02/2025
6:15 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
4:15 PM | Aura Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/24/2025
4:00 PM | Aura Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/18/2025
6:30 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:30 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:31 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:31 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:31 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
6:32 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
6:32 PM | Aura Biosciences (Subject)
Hopkins Janet Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
6:32 PM | Aura Biosciences (Subject)
Plavsic Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
10:56 AM | Aura Biosciences (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
4:51 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:51 PM | Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:51 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:52 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:52 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
8:09 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
8:09 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
8:10 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
8:10 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
6:20 PM | Aura Biosciences (Subject)
Long Focus Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
11/18/2024
8:06 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:32 PM | Aura Biosciences (Subject)
Hopkins Janet Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:50 PM | Aura Biosciences (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13G/A | |
The MAGA 7 Stocks: Huge Upside in 2025 (Ad) The Trump economy is back in full force, and it’s creating huge opportunities for investors.
With Trump pushing for lower taxes, fewer regulations, tariffs on foreign competitors, and domestic manufacturing dominance, some stocks are set to skyrocket in value—while others will be left behind.
That’s why we put together this free report revealing the 7 MAGA stocks poised to thrive in 2025. 🔻 Download the full report now and get the inside track on these 7 powerhouse stocks. |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Aura Biosciences (Subject)
| Form SC 13G/A | |
10/29/2024
7:33 PM | Aura Biosciences (Subject)
Feder Julie B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:33 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:38 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:23 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
7:28 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
7:18 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
5:06 PM | Aura Biosciences (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/21/2024
5:23 PM | Aura Biosciences (Issuer)
Feder Julie B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
7:08 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:21 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:21 PM | Aura Biosciences (Subject)
Feder Julie B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
4:10 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
8:22 PM | Aura Biosciences (Subject)
Plavsic Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
8:25 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:08 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:05 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:50 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:10 AM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/14/2024
3:37 PM | Aura Biosciences (Filer)
| Form 10-K/A | |
06/14/2024
3:42 PM | Aura Biosciences (Filer)
| Form DEFA14A | |
Buy AURA Stock Free AURA Stock Alerts